BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:03 PM
 | 
Aug 04, 2008
 |  BC Extra  |  Company News

FDA approves Cleviprex

FDA approved an NDA from The Medicines Co. (NASDAQ:MDCO) for IV Cleviprex clevidipine to...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >